H-1B Filings
10
Established sponsor. DOL labor condition applications on file.
Ascent Pharmaceuticals, INC. in NY (Manufacturing) is a sponsorship-and-safety profile: 10 H-1B LCAs plus an employer-specific OSHA injury record, with no WARN notices in this corpus.
Ascent Pharmaceuticals, INC. (NY): · 10 H-1B LCAs at a $100,750 disclosed median · OSHA Grade F (DART 3.27)
According to DOL OFLC H-1B disclosures, OSHA ITA injury logs, and state WARN Act notices, Ascent Pharmaceuticals, INC. in NY carries 10 H-1B wage filings on record, a $100,750 median wage (below the $124,488 national median), a weak F OSHA safety grade and no WARN layoff notices on file. Every figure is a federal filing, not an estimate; see methodology for coverage limits.
The record at a glance
Compared with the rest of PlainEmployers' federal employer corpus, H-1B filing volume ranks #5,046 of 51,370 sponsors in this corpus (about the 89th percentile), and disclosed median wage sits at the 29th percentile of 272,125 credible H-1B wage rows.
Figures above come from DOL H-1B LCAs and this employer's OSHA injury log; no WARN notices are on file here.
A weighted composite of DOL H-1B sponsorship and pay, OSHA establishment injury records, and WARN Act layoff notices, not culture, benefits, or "is this a good place to work." Missing tracks drop out and their weight redistributes so sparse records are not silently deflated.
Weights (redistributed when a track is N/A): Sponsorship scale (H-1B volume) 15% · Disclosed pay (H-1B wage percentile) 25% · Workplace safety (OSHA DART percentile) 35% · Layoff stability (WARN percentile) 25%. Sources: DOL OFLC · OSHA ITA · state WARN filings.
DOL LCA release change
H-1B Filings
10
Established sponsor. DOL labor condition applications on file.
Median H-1B Salary
$100,750
Below national median. Across 10 disclosed positions
OSHA Safety Grade
Grade F · DART 3.27
Riskier than industry average. vs 1.14 same 2-digit NAICS sector (OSHA ITA 2022–2023, hours-weighted)
Where Ascent Pharmaceuticals, INC.'s H-1B wage sits nationally
Median disclosed wage vs. all US employers with H-1B filings
$100,750 Top 71% higher than 29% of 272,125 US employers
Each bar is a $20K-wide band; taller bars hold more US employers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source DOL Office of Foreign Labor Certification, H-1B Disclosure Data · August 2026
| Field | Value | Source |
|---|---|---|
| Employer Name | Ascent Pharmaceuticals, INC. | DOL OFLC / OSHA |
| Industry | Manufacturing | NAICS / DOL |
| State | NY | U.S. Federal Records |
| H-1B Filings | 10 | DOL OFLC LCA Disclosure |
| H-1B Median Salary | $100,750 | DOL OFLC LCA Disclosure |
| OSHA Safety Grade | F | OSHA ITA |
| OSHA DART Rate | 3.27 | OSHA ITA Establishment Records |
| Tracks not on file | WARN notices | Empty by design, not estimated |
Ascent Pharmaceuticals, INC.'s values above reflect the most recent DOL Labor Condition Applications, OSHA Injury Tracking Application records on file for this employer in NY (Manufacturing). In this corpus, H-1B filing volume ranks #5,046 of 51,370 sponsors in this corpus (about the 89th percentile); disclosed median wage sits at the 29th percentile of 272,125 credible H-1B wage rows; OSHA DART rate is safer than roughly 27% of 214,554 employers with an establishment injury record.
| Job Title | Median |
|---|---|
| Sr. Quality Assurance Scientist | $225,670 |
| Quality Control Scientist | $119,800 |
| Sr. Regulatory Affairs Specialist | $110,500 |
| Quality Control Chemist | $104,700 |
| Quality Control Chemist | $100,750 |
| Maintenance Engineer | $81,100 |
| Analytical Chemist | $81,000 |
| Formulation Chemist | $78,500 |
| Manufacturing Chemist | $77,000 |
| Quality Assurance Chemist | $75,000 |
Ascent Pharmaceuticals, INC.'s most extreme placement is sponsorship scale: 10 H-1B LCAs rank higher than 89% of sponsors in this corpus (#5,046 of 51,370).
The establishment DART rate is 3.3, above the 1.1 sector norm (Grade F) across 20 reportable injuries on file.
FY2025 filings fell 60% from FY2024 (5 → 2).
No WARN Act mass-layoff notices are on file for Ascent Pharmaceuticals, INC. among Manufacturing employers we track.
Disclosed pay runs low: $100,750 median trails 71% of wage rows and sits under the $124,488 national median.
Ascent Pharmaceuticals, INC.'s DART rate (days away/restricted/transferred per 100 FTE) vs the hours-weighted 2-digit NAICS sector average from OSHA ITA 2022–2023 (Manufacturing).
Total reported injuries on file: 20.
Where Ascent Pharmaceuticals, INC. sits
Across the 201 Manufacturing sponsors in this corpus with both an H-1B filing count and a credible disclosed-wage median, Ascent Pharmaceuticals, INC. files more petitions than 0% of them and discloses a higher median wage than 4%, the selective, below-median pay quadrant. Filing volume is hiring scale, not pay; the axes are independent DOL OFLC disclosures (10 filings · $100,750 median here).
Each muted dot is one manufacturing peer from a filings-stratified sample of 42; the brand marker is Ascent Pharmaceuticals, INC.. Source: DOL Office of Foreign Labor Certification H-1B LCA disclosures (credible wages recomputed from per-position filings, excluding parse errors above $500k).
Ascent Pharmaceuticals, INC.'s nearest H-1B-filing peers in Manufacturing (home state NY). Each card links to that employer's federal-records profile.
Two federal-records peer sets for Ascent Pharmaceuticals, INC., both outside NY so the neighborhoods are not the same-industry VsCard above.
Nearest injury-rate peers outside NY (DART 3.27 here).
Peers are nearest-neighbor matches on disclosed filing counts and OSHA ITA DART rates; employers with fewer than 100 H-1B filings or fewer than 10 reported injuries are excluded from the comparison corpus.
What to check before working with Ascent Pharmaceuticals, INC.
For Ascent Pharmaceuticals, INC., read sponsorship pay (10 H-1B LCAs, median $100,750) next to the OSHA safety grade (F).
Ascent Pharmaceuticals, INC.'s figures are legally filed public records (DOL, OSHA, state WARN), not reviews or vendor estimates; a missing row is not proof the underlying activity never happened.
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from OSHA and the DOL Wage and Hour Division. Consult a qualified professional before making decisions based on this data.
Among 272,125 credible H-1B wage rows in this corpus, Ascent Pharmaceuticals, INC.'s disclosed median of $100,750 sits at the 29th percentile (below the $124,488 national median). The chart above uses a COUNT-exact percentile (rows below this wage ÷ total), not an interpolated estimate.
Ascent Pharmaceuticals, INC. has 10 H-1B filings on record, ranking #5,046 of 51,370 sponsors in this corpus (about the 89th percentile by volume). Filing volume is a sponsorship signal, not a headcount or hiring-quality score.
Ascent Pharmaceuticals, INC. carries Grade F from its establishment injury record (20 injuries on file; DART 3.27). That DART rate is safer than roughly 27% of 214,554 employers with an injury record in this corpus. Grades compare DART against industry averages, see the Interpreting Safety Grades guide.
Related guides: How OSHA safety grades are calculated · Using H-1B wage filings in salary negotiation
Read our methodology - how this data is sourced, computed, and verified.
This profile is rendered directly from DOL H-1B disclosure filings and OSHA Injury Tracking Application records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.